Consolidated Statement Of Cash Flows

LIFENET INSURANCE COMPANY - Filing #7258396

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
As at
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss)
5,993,000,000 JPY
5,993,000,000 JPY
0 JPY
5,992,000,000 JPY
JPY
JPY
JPY
JPY
JPY
JPY
5,734,000,000 JPY
JPY
JPY
-10,000,000 JPY
JPY
JPY
5,734,000,000 JPY
5,723,000,000 JPY
JPY
JPY
Depreciation and amortization
948,000,000 JPY
631,000,000 JPY
Impairment losses (reversal of impairment losses)
0 JPY
53,000,000 JPY
Other
63,000,000 JPY
43,000,000 JPY
Subtotal
6,430,000,000 JPY
5,459,000,000 JPY
Interest received
812,000,000 JPY
398,000,000 JPY
Dividends received
37,000,000 JPY
159,000,000 JPY
Interest paid
-13,000,000 JPY
-1,000,000 JPY
Net cash provided by (used in) operating activities
7,279,000,000 JPY
6,016,000,000 JPY
Cash flows from investing activities
Other
-468,000,000 JPY
-147,000,000 JPY
Net cash provided by (used in) investing activities
-14,295,000,000 JPY
-3,443,000,000 JPY
Cash flows from financing activities
Proceeds from issuance of shares
JPY
9,789,000,000 JPY
Purchase of treasury shares
0 JPY
0 JPY
Net cash provided by (used in) financing activities
-164,000,000 JPY
9,681,000,000 JPY
Net increase (decrease) in cash and cash equivalents
-7,180,000,000 JPY
12,253,000,000 JPY
Cash and cash equivalents
17,234,000,000 JPY
24,423,000,000 JPY
12,137,000,000 JPY
Effect of exchange rate changes on cash and cash equivalents
-8,000,000 JPY
32,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.